Schroder Investment Management Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-2,317
| Closed | -$569K | – | 1341 |
|
2022
Q3 | $569K | Hold |
2,317
| – | – | ﹤0.01% | 1118 |
|
2022
Q2 | $595K | Buy |
2,317
+596
| +35% | +$153K | ﹤0.01% | 1156 |
|
2022
Q1 | $565K | Buy |
1,721
+657
| +62% | +$216K | ﹤0.01% | 1205 |
|
2021
Q4 | $382K | Hold |
1,064
| – | – | ﹤0.01% | 1154 |
|
2021
Q3 | $346K | Hold |
1,064
| – | – | ﹤0.01% | 1257 |
|
2021
Q2 | $332K | Buy |
1,064
+357
| +50% | +$111K | ﹤0.01% | 1272 |
|
2021
Q1 | $225K | Hold |
707
| – | – | ﹤0.01% | 1312 |
|
2020
Q4 | $229K | Hold |
707
| – | – | ﹤0.01% | 1286 |
|
2020
Q3 | $185K | Hold |
707
| – | – | ﹤0.01% | 1190 |
|
2020
Q2 | $171K | Hold |
707
| – | – | ﹤0.01% | 1110 |
|
2020
Q1 | $106K | Sell |
707
-367
| -34% | -$55K | ﹤0.01% | 1183 |
|
2019
Q4 | $183K | Buy |
1,074
+389
| +57% | +$66.3K | ﹤0.01% | 1171 |
|
2019
Q3 | $120K | Sell |
685
-148
| -18% | -$25.9K | ﹤0.01% | 1179 |
|
2019
Q2 | $217K | Hold |
833
| – | – | ﹤0.01% | 1077 |
|
2019
Q1 | $238K | Buy |
+833
| New | +$238K | ﹤0.01% | 1063 |
|
2018
Q3 | – | Sell |
-3,650
| Closed | -$1.51M | – | 1354 |
|
2018
Q2 | $1.51M | Sell |
3,650
-7,053
| -66% | -$2.92M | ﹤0.01% | 865 |
|
2018
Q1 | $3.11M | Sell |
10,703
-162
| -1% | -$47.1K | 0.01% | 791 |
|
2017
Q4 | $2.04M | Sell |
10,865
-2,419
| -18% | -$453K | ﹤0.01% | 895 |
|
2017
Q3 | $2.16M | Buy |
13,284
+8,175
| +160% | +$1.33M | ﹤0.01% | 879 |
|
2017
Q2 | $716K | Buy |
+5,109
| New | +$716K | ﹤0.01% | 1024 |
|